2013 Q2 Form 10-Q Financial Statement

#000146310113000012 Filed on August 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $58.17M $55.70M
YoY Change 4.43% 88.22%
Cost Of Revenue $41.88M $42.10M
YoY Change -0.51% 69.84%
Gross Profit $16.28M $13.60M
YoY Change 19.73% 182.94%
Gross Profit Margin 28.0% 24.42%
Selling, General & Admin $13.29M $12.45M
YoY Change 6.75% 52.7%
% of Gross Profit 81.62% 91.54%
Research & Development $8.484M $8.655M
YoY Change -1.98% 40.89%
% of Gross Profit 52.1% 63.64%
Depreciation & Amortization $1.700M $1.400M
YoY Change 21.43% 100.0%
% of Gross Profit 10.44% 10.29%
Operating Expenses $21.78M $21.11M
YoY Change 3.17% 47.63%
Operating Profit -$5.491M -$7.505M
YoY Change -26.84% -20.92%
Interest Expense $484.0K $3.405M
YoY Change -85.79% -781.0%
% of Operating Profit
Other Income/Expense, Net -$781.0K -$3.729M
YoY Change -79.06% 367.29%
Pretax Income -$6.272M -$11.23M
YoY Change -44.17% 9.07%
Income Tax $124.0K $151.0K
% Of Pretax Income
Net Earnings -$6.396M -$11.39M
YoY Change -43.82% 10.66%
Net Earnings / Revenue -11.0% -20.44%
Basic Earnings Per Share
Diluted Earnings Per Share -$153.8K -$288.6K
COMMON SHARES
Basic Shares Outstanding 41.62M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.00M $67.00M
YoY Change -49.25% 88.2%
Cash & Equivalents $33.98M $66.97M
Short-Term Investments
Other Short-Term Assets $2.700M $2.600M
YoY Change 3.85% 420.0%
Inventory $17.91M $31.00M
Prepaid Expenses
Receivables $32.10M $10.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $86.69M $110.5M
YoY Change -21.54% 90.85%
LONG-TERM ASSETS
Property, Plant & Equipment $25.14M $24.70M
YoY Change 1.79% 105.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.513M $1.400M
YoY Change 8.07% -50.0%
Total Long-Term Assets $26.65M $26.00M
YoY Change 2.52% 76.87%
TOTAL ASSETS
Total Short-Term Assets $86.69M $110.5M
Total Long-Term Assets $26.65M $26.00M
Total Assets $113.3M $136.5M
YoY Change -16.96% 88.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.01M $25.60M
YoY Change -60.89% 79.02%
Accrued Expenses $19.35M $12.50M
YoY Change 54.78% 145.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.365M $6.500M
YoY Change -48.23% 132.14%
Total Short-Term Liabilities $33.98M $45.20M
YoY Change -24.82% 88.33%
LONG-TERM LIABILITIES
Long-Term Debt $6.531M $6.800M
YoY Change -3.96% -66.5%
Other Long-Term Liabilities $394.0K $14.40M
YoY Change -97.26% 171.7%
Total Long-Term Liabilities $6.925M $21.20M
YoY Change -67.33% -17.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.98M $45.20M
Total Long-Term Liabilities $6.925M $21.20M
Total Liabilities $69.00M $66.40M
YoY Change 3.92% 33.87%
SHAREHOLDERS EQUITY
Retained Earnings -$143.8M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.35M $70.10M
YoY Change
Total Liabilities & Shareholders Equity $113.3M $136.5M
YoY Change -16.96% 88.02%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$6.396M -$11.39M
YoY Change -43.82% 10.66%
Depreciation, Depletion And Amortization $1.700M $1.400M
YoY Change 21.43% 100.0%
Cash From Operating Activities -$1.000M -$17.70M
YoY Change -94.35% 145.83%
INVESTING ACTIVITIES
Capital Expenditures -$1.800M -$3.400M
YoY Change -47.06% -20.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.800M -$3.400M
YoY Change -47.06% -20.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K 56.30M
YoY Change -99.47% 241.21%
NET CHANGE
Cash From Operating Activities -1.000M -17.70M
Cash From Investing Activities -1.800M -3.400M
Cash From Financing Activities 300.0K 56.30M
Net Change In Cash -2.500M 35.20M
YoY Change -107.1% 604.0%
FREE CASH FLOW
Cash From Operating Activities -$1.000M -$17.70M
Capital Expenditures -$1.800M -$3.400M
Free Cash Flow $800.0K -$14.30M
YoY Change -105.59% 393.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 enph Conversion Of Convertible Preferred Stock Into Common Stock
ConversionOfConvertiblePreferredStockIntoCommonStock
25171017 shares
enph Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 USD
CY2013Q2 enph Line Of Credit Number Of Debt Agreements
LineOfCreditNumberOfDebtAgreements
3 debt_agreement
enph Offering Costsnot Yet Paid
OfferingCostsnotYetPaid
0 USD
enph Offering Costsnot Yet Paid
OfferingCostsnotYetPaid
204000 USD
CY2012Q2 enph Other Estimated Offering Costs
OtherEstimatedOfferingCosts
4800000 USD
enph Reclassificationof Preferred Stock Warrant Liability
ReclassificationofPreferredStockWarrantLiability
0 USD
enph Reclassificationof Preferred Stock Warrant Liability
ReclassificationofPreferredStockWarrantLiability
879000 USD
CY2012Q2 enph Stock Issued During Period Shares Conversion Of Convertible Securities And Paid In Kind Interest
StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesAndPaidInKindInterest
3533988 shares
CY2012Q2 enph Underwriters Discounts And Commissions
UnderwritersDiscountsAndCommissions
3300000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10012000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11272000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27743000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32104000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19348000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19266000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
93000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
52000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
183629000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
188082000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1708000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2910000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1475000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1002000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1052000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1177000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3903000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
215000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8518000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8582000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7564000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8548000 shares
CY2012Q4 us-gaap Assets
Assets
122291000 USD
CY2013Q2 us-gaap Assets
Assets
113348000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
94998000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
86694000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1692000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
305000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45294000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33976000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66969000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51524000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15445000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11318000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40856000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41739000 shares
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6177000 USD
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40856000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41739000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
0 USD
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There have been no material changes in the Company's significant accounting policies, as compared to the significant accounting policies described in the Company's Annual Report on Form 10-K for the year ended December 31, 2012. </font></div></div>
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16761000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11396000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21552000 USD
CY2012Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
21200000 USD
us-gaap Cost Of Revenue
CostOfRevenue
75259000 USD
us-gaap Cost Of Revenue
CostOfRevenue
75389000 USD
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
42096000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
41883000 USD
CY2013Q2 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
124000 USD
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
306000 USD
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
216000 USD
CY2012Q2 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
151000 USD
CY2012Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
6.00
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1258000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
933000 USD
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9303000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7537000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3369000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2451000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
17000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-187000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12900000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
8124000 USD
us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
3698000 USD
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-110000 USD
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-31000 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6091000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5926000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11962000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11787000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
16284000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
13601000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21353000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16496000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6272000 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.41
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.05
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19738000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1937000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1317000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
526000 USD
us-gaap Interest Expense
InterestExpense
4884000 USD
us-gaap Interest Expense
InterestExpense
948000 USD
us-gaap Gross Profit
GrossProfit
28485000 USD
us-gaap Gross Profit
GrossProfit
22908000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-15202000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5491000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7505000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-16785000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11234000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.29
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.15
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
151000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
306000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
124000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
216000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3174000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16719000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4389000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7810000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-21402000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2091000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
484000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
3405000 USD
us-gaap Interest Paid
InterestPaid
715000 USD
us-gaap Interest Paid
InterestPaid
904000 USD
us-gaap Net Income Loss
NetIncomeLoss
-16802000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15810000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17620000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
19843000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
17906000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2223000 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2096000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
65636000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
69001000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122291000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113348000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
33983000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33855000 USD
CY2012Q4 us-gaap Loans Payable Current
LoansPayableCurrent
2384000 USD
CY2013Q2 us-gaap Loans Payable Current
LoansPayableCurrent
3365000 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
11061000 USD
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
9896000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3365000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2384000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6531000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8677000 USD
CY2013Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
6531000 USD
CY2012Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
8677000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55286000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
298000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3467000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8013000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31845000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7962000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21569000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-6396000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-11385000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3729000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4568000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1294000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-781000 USD
us-gaap Operating Expenses
OperatingExpenses
43687000 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2708000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2118000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
58609000 USD
CY2012Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
53800000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2600000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
44000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1534000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
21106000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
21775000 USD
us-gaap Operating Expenses
OperatingExpenses
39693000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1513000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1752000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
17000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
41000 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
219000 USD
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-11000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
394000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
307000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-297000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-346000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
316000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-324000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1828000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3467000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8013000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
22220856 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
21338000 USD
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
11412000 USD
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
26777000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8738000 USD
CY2012Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2220000 USD
CY2013Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
7987000 USD
CY2012Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
15260000 USD
CY2013Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
18790000 USD
CY2012Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
9192000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25141000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25541000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
63000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
40000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4076000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1196000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17510000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8484000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16497000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8655000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-143828000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127026000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
55697000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
98297000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
58167000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
103744000 USD
CY2012Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
900000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11409000 USD
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6360000 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7365000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14215000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1708000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2910000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
210000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
681000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8169000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7924000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.28
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.61
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.58
CY2013Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
2700000 USD
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
1200000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.64
CY2012Q2 us-gaap Share Price
SharePrice
6.00
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2685000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1024000 USD
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
4700000 USD
CY2012Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
28700000 shares
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10315151 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
716000 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
21204000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
44347000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
56655000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
520000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events, and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. Significant estimates and assumptions reflected in the financial statements include revenue recognition, inventory valuation and accrued warranty obligations. Actual results could differ from those estimates.</font></div></div>
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39461000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20584000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41384000 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41617000 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001463101
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41760714 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Enphase Energy, Inc.

Files In Submission

Name View Source Status
0001463101-13-000012-index-headers.html Edgar Link pending
0001463101-13-000012-index.html Edgar Link pending
0001463101-13-000012.txt Edgar Link pending
0001463101-13-000012-xbrl.zip Edgar Link pending
enph-20130630.xml Edgar Link completed
enph-20130630.xsd Edgar Link pending
enph-20130630_cal.xml Edgar Link unprocessable
enph-20130630_def.xml Edgar Link unprocessable
enph-20130630_lab.xml Edgar Link unprocessable
enph-20130630_pre.xml Edgar Link unprocessable
enph0630201310-q.htm Edgar Link pending
enph06302013ex311.htm Edgar Link pending
enph06302013ex312.htm Edgar Link pending
enph06302013ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending